Terms: = Lung cancer AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Treatment
24 results:
1. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
[TBL] [Abstract] [Full Text] [Related]
2. Pembrolizumab monotherapy for non-small cell lung cancer (NSCLC): can patient stratification be improved in the UK Tayside population? A retrospective cohort study.
Mander ES; Merrick CB; Nicholson HA; Lord HK; Ferguson MJ; Smith G
BMJ Open; 2023 Nov; 13(11):e076715. PubMed ID: 37989364
[TBL] [Abstract] [Full Text] [Related]
3. Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Sworder BJ; Kurtz DM; Alig SK; Frank MJ; Shukla N; Garofalo A; Macaulay CW; Shahrokh Esfahani M; Olsen MN; Hamilton J; Hosoya H; Hamilton M; Spiegel JY; Baird JH; Sugio T; Carleton M; Craig AFM; Younes SF; Sahaf B; Sheybani ND; Schroers-Martin JG; Liu CL; Oak JS; Jin MC; Beygi S; Hüttmann A; Hanoun C; Dührsen U; Westin JR; Khodadoust MS; Natkunam Y; Majzner RG; Mackall CL; Diehn M; Miklos DB; Alizadeh AA
Cancer Cell; 2023 Jan; 41(1):210-225.e5. PubMed ID: 36584673
[TBL] [Abstract] [Full Text] [Related]
4. Irinotecan and Gemcitabine as Second-Line treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
Koda Y; Kuribayashi K; Doi H; Kitajima K; Nakajima Y; Ishigaki H; Nakamura A; Minami T; Takahashi R; Yokoi T; Kijima T
Oncology; 2021; 99(3):161-168. PubMed ID: 33053560
[TBL] [Abstract] [Full Text] [Related]
5. Identification of aspartame-induced haematopoietic and lymphoid tumours in rats after lifetime treatment.
Tibaldi E; Gnudi F; Panzacchi S; Mandrioli D; Vornoli A; Manservigi M; Sgargi D; Falcioni L; Bua L; Belpoggi F
Acta Histochem; 2020 Jul; 122(5):151548. PubMed ID: 32622430
[TBL] [Abstract] [Full Text] [Related]
6. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing, China.
Yin X; Xu Y; Man X; Liu L; Jiang Y; Zhao L; Cheng W
Cancer Med; 2019 Jun; 8(6):3250-3260. PubMed ID: 31062522
[TBL] [Abstract] [Full Text] [Related]
7. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
8. How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
Roengvoraphoj O; Eze C; Wijaya C; Dantes M; Taugner J; Tufman A; Huber RM; Bartenstein P; Belka C; Manapov F
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2103-2109. PubMed ID: 29876620
[TBL] [Abstract] [Full Text] [Related]
9. lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Richards TB; Henley SJ; Puckett MC; Weir HK; Huang B; Tucker TC; Allemani C
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5079-5099. PubMed ID: 29205305
[TBL] [Abstract] [Full Text] [Related]
10. pax5 Re-expression in H460 Cells Treated with the Combination of Demethylating Agent and Histone Deacetylase Inhibitor is Associated with the Enhancement of P53 Binding to pax5 Promoter Region.
Liang Y; Zeng J; Jelicks L; Ma S; Liu J; Mei J; Perez-Soler R; Zou Y
Curr Cancer Drug Targets; 2017; 17(2):169-176. PubMed ID: 27029827
[TBL] [Abstract] [Full Text] [Related]
11. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T
J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424
[TBL] [Abstract] [Full Text] [Related]
12. Hypocalcaemia in patients with metastatic bone disease treated with denosumab.
Body JJ; Bone HG; de Boer RH; Stopeck A; Van Poznak C; Damião R; Fizazi K; Henry DH; Ibrahim T; Lipton A; Saad F; Shore N; Takano T; Shaywitz AJ; Wang H; Bracco OL; Braun A; Kostenuik PJ
Eur J Cancer; 2015 Sep; 51(13):1812-21. PubMed ID: 26093811
[TBL] [Abstract] [Full Text] [Related]
13. Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.
Kanteti R; El-Hashani E; Dhanasingh I; Tretiakova M; Husain AN; Sharma S; Sharma J; Vokes EE; Salgia R
BMC Cancer; 2014 Mar; 14():185. PubMed ID: 24628993
[TBL] [Abstract] [Full Text] [Related]
14. A rare case of anaplastic variant of diffuse large B-cell lymphoma presenting as a lung primary.
Kos Z; Burns BF; Gomes MM; Sekhon HS
Int J Surg Pathol; 2014 Apr; 22(2):167-71. PubMed ID: 23775019
[TBL] [Abstract] [Full Text] [Related]
15. Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.
Oshita F; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
Cancer Chemother Pharmacol; 2013 Feb; 71(2):345-50. PubMed ID: 23124649
[TBL] [Abstract] [Full Text] [Related]
16. Diabetes and lung cancer among postmenopausal women.
Luo J; Chlebowski R; Wactawski-Wende J; Schlecht NF; Tinker L; Margolis KL
Diabetes Care; 2012 Jul; 35(7):1485-91. PubMed ID: 22619084
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic and prognostic use of bone turnover markers.
Joerger M; Huober J
Recent Results Cancer Res; 2012; 192():197-223. PubMed ID: 22307377
[TBL] [Abstract] [Full Text] [Related]
18. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.
Chlebowski RT; Schwartz AG; Wakelee H; Anderson GL; Stefanick ML; Manson JE; Rodabough RJ; Chien JW; Wactawski-Wende J; Gass M; Kotchen JM; Johnson KC; O'Sullivan MJ; Ockene JK; Chen C; Hubbell FA;
Lancet; 2009 Oct; 374(9697):1243-51. PubMed ID: 19767090
[TBL] [Abstract] [Full Text] [Related]
19. Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses.
Tillman GF; Pawlicki T; Koong AC; Goodman KA
Dis Esophagus; 2008; 21(5):437-44. PubMed ID: 19125798
[TBL] [Abstract] [Full Text] [Related]
20. Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.
Belinsky SA; Grimes MJ; Casas E; Stidley CA; Franklin WA; Bocklage TJ; Johnson DH; Schiller JH
Br J Cancer; 2007 Apr; 96(8):1278-83. PubMed ID: 17406356
[TBL] [Abstract] [Full Text] [Related]
[Next]
